Sermorelin
Prompts the pituitary gland to release more of your own growth hormone, supporting sleep and recovery.
- Vial
- 6.0 mL
- Strength
- 1.5 mg/mL
- Typical dose
- 300 mcg (20 units)
- Schedule
- At bedtime
- Per vial
- About 30 doses
- FDA status
- Previously FDA approved; no longer sold as a brand
What it is
Sermorelin is a lab-made version of the first 29 amino acids of growth-hormone-releasing hormone (GHRH). It prompts the pituitary gland to release more of your own growth hormone.
What the research shows
Sermorelin was once FDA approved (as Geref) to diagnose and treat growth hormone deficiency in children. The brand was discontinued in 2008 for business reasons, not safety concerns. Today it's prepared by compounding pharmacies.
How it's used
Sermorelin is commonly supplied as a 6.0 mL vial at 1.5 mg/mL. A typical dose is 300 mcg (20 units), injected under the skin, at bedtime. Your prescriber sets your exact dose and schedule.
Common questions
Why at bedtime?
G
r
o
w
t
h
h
o
r
m
o
n
e
r
e
l
e
a
s
e
p
e
a
k
s
d
u
r
i
n
g
d
e
e
p
s
l
e
e
p
,
s
o
a
b
e
d
t
i
m
e
d
o
s
e
m
a
t
c
h
e
s
t
h
a
t
r
h
y
t
h
m
.
I
t
'
s
t
y
p
i
c
a
l
l
y
t
a
k
e
n
o
n
a
n
e
m
p
t
y
s
t
o
m
a
c
h
.
How is it different from taking growth hormone?
I
t
e
n
c
o
u
r
a
g
e
s
y
o
u
r
b
o
d
y
t
o
m
a
k
e
i
t
s
o
w
n
g
r
o
w
t
h
h
o
r
m
o
n
e
,
s
o
y
o
u
r
n
a
t
u
r
a
l
f
e
e
d
b
a
c
k
c
o
n
t
r
o
l
s
s
t
a
y
i
n
p
l
a
c
e
.
Is it safe?
E
v
e
r
y
p
e
p
t
i
d
e
h
a
s
p
o
s
s
i
b
l
e
s
i
d
e
e
f
f
e
c
t
s
,
a
n
d
m
a
n
y
h
a
v
e
l
i
m
i
t
e
d
l
o
n
g
-
t
e
r
m
r
e
s
e
a
r
c
h
i
n
p
e
o
p
l
e
.
Y
o
u
r
p
r
o
v
i
d
e
r
r
e
v
i
e
w
s
y
o
u
r
h
e
a
l
t
h
h
i
s
t
o
r
y
b
e
f
o
r
e
p
r
e
s
c
r
i
b
i
n
g
a
n
d
c
a
n
e
x
p
l
a
i
n
t
h
e
r
i
s
k
s
f
o
r
y
o
u
.
Good to know
- Available by prescription only, after an evaluation by a licensed provider.
- Not FDA approved for the uses described here.
- If you compete in a sport that drug-tests, this peptide is on the World Anti-Doping Agency (WADA) prohibited list.
- See the side-effect guide for what to watch for.
